title: Genomics in target and drug discovery.
abstract: Genomics-based discovery of novel therapeutic drug targets requires the design of well-controlled biological or pharmacological experiments with experimental questions and hypotheses that relate to the therapeutic area of interest. This will aid the validation level of differentially expressed genes and hence facilitate the de-selection of the genes that are identified in microarray experiments. We here provide an example of how this approach is followed in the manipulation of human macrophage foam cells towards the discovery of novel drug targets for treatment of atherosclerosis.
authors.affiliation: Organon Research Laboratories, Department of Target Discovery, Newhouse, Lanarkshire ML1 5SH, Scotland, U.K. marcel.vanduin@organon.com
authors.forename: M
authors.initials: M
authors.lastname: van Duin
authors.forename: H
authors.initials: H
authors.lastname: Woolson
authors.forename: D
authors.initials: D
authors.lastname: Mallinson
authors.forename: D
authors.initials: D
authors.lastname: Black
mesh_terms: D001161:Arteriosclerosis / Q000188:drug therapy; D015195:Drug Design; D005786:Gene Expression Regulation; D023281:Genomics / Q000379:methods*; D006801:Humans; D008264:Macrophages / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis